Harbor-UCLA

Torrance, California 90509

1 studies enrolling now · 12 studies all time

What they study most

Aortic Dissection, Blunt Thoracic Aortic Injury, COPD, Coronary Artery Disease, Emergency Department, End of Life, HIV Infections, Humeral Fractures, Proximal, Pulmonary Arterial Hypertension, Radiographic Contrast Agent Nephropathy, Thoracic Aortic Aneurysms

Studies at this site

• SELUTION 4 De Novo Small Vessel IDE Trial — Recruiting now
• Wishes to Improve Support and Humanity at End-of-life in Safety-net Hospitals — Running, not enrolling
• Evaluation of the Safety and Efficacy of TLD in Patients with COPD — Running, not enrolling
• Improving Quality & Equity of Emergency Care Decisions (IQED) — Withdrawn before enrolling
• Study to Determine if the Valiant Stent Graft is Safe and Effective in Treating Patients Who Have a Blunt Thoracic Aortic Injury — Completed
• Study to Evaluate the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System (Valiant Captivia) for the Treatment of Acute, Complicated Type B Aortic Dissections — Completed
• Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE) — Stopped early
• CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery — Completed
• Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients — Completed
• Post-Approval Prospective Study - Conventus CAGE™ PH for Use in Proximal Humerus Fracture Fixation — Stopped early
• Contrast Media Reduction and Removal in Patients With Chronic Kidney Disease (CKD) (PRESERV) — Stopped early
• Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1) — Completed